Novartis (NVS) Insider Trading & Ownership $104.86 +0.06 (+0.06%) (As of 12:03 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends There is no recent insider trading on record for Novartis, but the stock has been recently traded by U.S. Congress members, who may have more information about the industry than the general public. Get NVS Insider Trade Alerts Want to know when executives and insiders are buying or selling Novartis stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Porter & CompanyThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry. Novartis Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellAverage Share PriceTotal Transaction4/9/2024Sheldon WhitehouseU.S. Congress Member (D-RI)Sell$95.80$1,001 - $15,0009/20/2023Sheldon WhitehouseU.S. Congress Member (D-RI)Buy$103.58$15,001 - $50,0007/10/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Sell$96.55$50,001 - $100,0004/26/2023Thomas R. CarperU.S. Congress Member (D-DE)Buy$102.54$1,001 - $15,0003/31/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Buy$92.00$50,001 - $100,0002/27/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Sell$85.55$15,001 - $50,0001/31/2023Kevin HernU.S. Congress Member (R-OK)Sell$90.62$1,001 - $15,0003/16/2022John H. RutherfordU.S. Congress Member (R-FL)Sell$84.64$1,001 - $15,0002/28/2022Donald S. Beyer, Jr.U.S. Congress Member (D-VA)Sell$87.46$1,001 - $15,0001/27/2022Donald S. Beyer, Jr.U.S. Congress Member (D-VA)Buy$85.14$1,001 - $15,00012/22/2021Donald S. Beyer, Jr.U.S. Congress Member (D-VA)Sell$86.31$1,001 - $15,00012/15/2021Shelley Moore CapitoU.S. Congress Member (R-WV)Sell$81.52$1,001 - $15,000 (Data available from 1/1/2013 forward) NVS Insider Trading Activity - Frequently Asked Questions What percentage of Novartis stock is owned by insiders? 0.01% of Novartis stock is owned by insiders. Learn more on NVS's insider holdings. Which members of congress are trading Novartis? Sheldon Whitehouse (D-RI) has sold shares of Novartis in the last year totaling $8,000. Novartis Key ExecutivesDr. Vasant Narasimhan M.D. (Age 48)Chief Executive Officer Compensation: $8.01MMr. Harry Kirsch (Age 59)Chief Financial Officer Compensation: $3.99MMr. Victor Bulto (Age 46)President of US Compensation: $3.28MDr. Patrick Horber M.D. (Age 54)President of International Compensation: $7.31MDr. Steffen Lang Ph.D. (Age 57)President of Operations Compensation: $2.34MPaul PenepentHead of Group Financial Reporting and AccountingMs. Sloan SimpsonGlobal Head of Investor RelationsDr. Klaus Moosmayer Ph.D. (Age 56)Chief Ethics, Risk & Compliance Officer Compensation: $1.55MMs. Karen L. Hale (Age 56)Chief Legal Officer Compensation: $2.34MDr. Robert Kowalski Pharm.D. (Age 56)Chief People & Organization Officer Compensation: $2.1M More Insider Trading Tools from MarketBeat Related Companies NVO Insider Trades AZN Insider Trades SNY Insider Trades GSK Insider Trades TAK Insider Trades BNTX Insider Trades BGNE Insider Trades TEVA Insider Trades MRNA Insider Trades VTRS Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Zeta Global Holdings Insiders Buy Stock After Short-ReportServiceNow: Will the High-Flyer Finally Split in 2024?Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in Buybacks This page (NYSE:NVS) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novartis AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Novartis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
